ETEunicia Tan

Eunicia Tan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Eunicia Tan has a total of 102 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Secondary analysis of the 2021–2023 Sepsis Epidemiology in Australian and New Zealand Children Observational Dataset: Association Between Presenting Venous Lactate Concentration and 72-Hour Outcomes

    by Elliot Long, Stephen Hearps, Warwick Butt, Tom Rozen, James Williams, Amanda Williams, Ben Gelbart, Sarah McNab, Meredith L. Borland, Jarrod Cross, et al.

    Objectives: In pediatric patients with sepsis, we hypothesized that the initial venous lactate concentration would be associated with subsequent need for extracorporeal life support (ECLS) or death within 72 hours. Design: A planned secondary analysis of data from the multicenter, two-country Sepsis Epidemiology Emergency Departments (SENTINEL) study, collected 2021–2023. Setting: Acute care hospitals in Australia and New Zealand. Patients: SENTINEL participants were children of 0 to less than 18 years with suspected sepsis admitted to the hospital through 11 emergency departments. Interventions: None. Measurements and Main Results: We used the initial venous lactate concentration (sampling within 4 hr of hospital arrival) as an explanatory variable for subsequent need for ECLS or death within 72 hours. In 4806 children, with a median (interquartile range [IQR]) age of 1.9 years (IQR, 0.2–6.7 yr), 2651 children (55.2%) were males, and 33 children (0.7%) received ECLS or died within 72 hours. The best-performing initial lactate concentration associated with ECLS or death within 72 hours was 3.5 mmol/L and was observed in 745 of 4806 children (15.5%), including 24 of 33 children requiring ECLS or who died within 72 hours. As a “diagnostic” test, lactate greater than or equal to 3.5 mmol/L had sensitivity (95% CI) of 72.7% (95% CI, 54.5–86.7%), specificity of 84.9% (95% CI, 83.9–85.9%), and area under the receiver-operating characteristics curve of 0.79 (95% CI, 0.71–0.87) for ECLS or death within 72 hours, which are in the acceptable-to-fair category. That is, a 4-hour lactate concentration greater than or equal to 3.5 mmol/L takes the pre- to posttest probability of ECLS/death from 0.7% to 3.2%. Conclusions: In this secondary analysis of the 2021–2023 SENTINEL dataset, we have found that at the time children are hospitalized with suspected community-acquired sepsis, an initial venous lactate greater than or equal to 3.5 mmol/L has an acceptable-to-fair association with subsequent need for ECLS, or death, within 72 hours. Clinicians will need to decide whether such testing on its own is useful in decision-making.

  • Open Access

    Development of a Binational Clinical Registry for Emergency Care: Data Completeness Across 11 Australian and Aotearoa New Zealand ED Networks

    by G. M. O'REilly, P. Buntine, J. Furyk, L. Hannon, A. Hermiz, P. G. Jones, A. Rogan, E. Tan, D. Tham, A. Wong, et al.

    Objective: The primary aim of this project was to test the feasibility of collating valid and useful ED data to inform the future establishment of a binational (i.e., Australia and Aotearoa New Zealand) clinical registry for emergency care. A secondary aim of this project was to utilise multi‐site ED data to assess the crude impact of COVID‐19 restrictions on overall ED presentations. Methods: This was a retrospective observational study using data routinely collected by EDs. The inclusion criteria were all patients presenting to participating EDs between 2017 and 2020. The primary outcome was data completeness. The secondary outcome was the number of ED presentations. Variables for which there was at least 80% data completeness across all participating sites were eligible for simple demonstrations of multi‐jurisdictional analyses. Results: There were data for 11 ED networks and 4,405,762 ED presentations. There were just nine variables which met the 80% completeness cutoff: network and site identification, birthdate, gender, First Nations self‐identification, ED arrival date and time, ED arrival mode, triage category, ED triage date and time. Compared to the expected number of overall annual ED presentations, there was a reduction of 16% (95% CI 14% to 17%) in the actual number of overall ED presentations in 2020. Conclusions: Data completeness for routinely collected data collated from multiple sites was satisfactory for just a small number of variables. These findings inform the opportunities and challenges to establishing a binational clinical registry for emergency care.

  • Open Access

    Digital tools for recruitment and retention of participants in paediatric clinical research: a scoping review

    by Eunicia Tan, Kate Loveys, William Ali, Christopher J. D. McKinlay, Stuart R. Dalziel

    Digital tools are increasingly used to support recruitment and retention of participants in paediatric research, particularly since the COVID-19 pandemic. However, the extent of the evidence supporting this method in paediatric populations has yet to be evaluated. This scoping review aimed to review the literature on digital tools for recruitment and/or retention of participants in paediatric research, including emerging evidence following the pandemic. A scoping review was conducted following Joanna Briggs Institute methodology. We included peer-reviewed quantitative, qualitative, and mixed-method studies evaluating a digital tool for recruitment or retention in paediatric research in any patient population aged <13 years. Records were identified from systematic database searches with a librarian (EMBASE, MEDLINE, CINAHL), limited to English, from 2013 onwards (last search 03/07/2024), and manual searches. Records were screened and extracted independently in duplicate. The data were charted and narratively summarised. Sixty-one out of 4988 records were included. Most evaluations used an observational design; only 5 (8%) involved a randomised experiment. The host studies were mostly aiming to recruit children aged 5-12 years (n = 42; 69%), with a predominantly health promotion (n = 18; 30%), developmental (n = 12; 20%), or oncology (n = 9; 15%) focus. Most studies used multi-component digital interventions for recruitment (n = 39/53; 74%) or retention (n = 17/31; 55%). Social media (n = 33/52; 62%) and websites (n = 19/53; 36%) were most commonly used for recruitment, whereas text/instant messaging (n = 17/31; 55%) and email (n = 11/31; 36%) were the most common retention strategies. The estimates of recruitment and retention rates, and reach per digital tool varied widely between studies. Strategies in underserved populations reflected those used most commonly overall. Multi-component digital strategies were found to support a high rate of retention (84.1-90.7%) during pandemic restrictions. This scoping review highlights the broad array of digital tools that have been used to support recruitment and retention in studies of infants and children, including in subgroups of underserved populations and in response to the COVID-19 pandemic. Most evaluations were observational and examined multi-component digital interventions. The lack of studies with a robust analytical design in the literature signals a need for further high-quality, randomised, within-study evaluations following standardised reporting criteria. The protocol was registered on the Open Science Framework (OSF) at https://osf.io/ybfhr/. Registered on July 5 2024.

  • Open Access

    Paediatric Fever Management Practices and Antipyretic Use Among Doctors and Nurses in Australian Emergency Departments

    by Anastasia Mutic, Rui Zhi Tan, Eunicia Tan, Michael C. Fahey, Emily Callander, Libby Haskell, Shane George, Meredith L. Borland, Naomi Loftus, Jeremy Furyk, et al.

    Objectives: To examine variation in practice and adherence to international clinical guidelines for the management of fever among Australian Emergency Department (ED) clinicians. Methods: Cross‐sectional survey across 22 Australian EDs. Clinical vignettes were used to determine compliance with international best practice guidelines (use of antipyretic monotherapy to alleviate fever‐associated child distress) for paediatric fever treatment. Comparisons were made between specialist paediatric EDs and general (non‐specialist paediatric) EDs, and between medical and nursing staff. Results: Of 539 survey respondents (300 doctors, 239 nurses; overall response rate 65.9%), only 9.3% (50/539, 95% confidence interval [CI] 7.1%–12.0%) adhered to evidence‐based practice guidelines. Specialist paediatric ED clinicians demonstrated less than half the adherence of those from general EDs (5.4% [11/204] vs. 12.4% [38/307], difference −7.0%, 95% CI −11.7% to −1.9%). In a febrile settled child with normal hydration, the proportion of respondents who opted for antipyretics more than doubled in the context of elevated vital signs (40.4% [218/539] vs. 83.1% [44/539], difference −42.7%, 95% CI −46.8% to −38.2%). Nearly half of respondents (239/539, 46.8%, 95% CI 42.4%–51.2%) endorsed giving combined antipyretic therapy. In a febrile settled child, most participants would give antipyretics for temperature reduction (453/539, 84.0%, 95% CI 80.7%–86.9%) and for decreased fluid intake (468/539, 87.5%, 95% CI 84.4%–90.0%). Over one‐third (192/539, 36.0%, 95% CI 32.1%–40.2%) recommended using antipyretics for febrile convulsion prevention during the current illness. Conclusions: Fewer than 10% of Australian ED clinicians self‐report practice consistent with international consensus recommendations for paediatric fever management.


  • Open Access

    Australian Emergency Department Doctors and Nurses' Perspectives on the Duration of Persistent Tachycardia in Children

    by Anastasia Mutic, Eunicia Tan, Michael Fahey, Emily Callander, Libby Haskell, Shane George, Meredith Borland, Naomi Loftus, Jessica Kasza, Jeremy Furyk, et al.

    Objective: To explore time thresholds for ‘persistent tachycardia’ in children among Australian emergency department clinicians.Methods: Online cross‐sectional survey of emergency department clinicians. Respondents were asked to indicate the duration in hours they considered that a tachycardia in a child would be classified as ‘persistent’.Results: Among 499 respondents, 304 (60.9%) identified tachycardia as ‘persistent’ by 2 h, and 471 (94.3%) by 4 h; the most common response was 2 h (147 (51.2%) doctors; 78 (36.8%) nurses).Conclusions: Time based thresholds for ‘persistent tachycardia’ differ. This has implications for its use in rapid‐response systems and early recognition of serious illness.

  • Open Access

    Prospective observational study to assess the performance accuracy of clinical decision rules in children presenting to emergency departments with possible cervical spine injuries: the Study of Neck Injuries in Children (SONIC)

    by Natalie Phillips, Geoffrey N Askin, Gavin A Davis, Sharon O’bRien, Meredith L Borland, Amanda Williams, Amit Kochar, Blessy John-Denny, Sarah Watson, Shane George, et al.

    Introduction Paediatric cervical spine injury (CSI) is uncommon but can have devastating consequences. Many children, however, present to emergency departments (EDs) for the assessment of possible CSI. While imaging can be used to determine the presence of injuries, these tests are not without risks and costs, including exposure to radiation and associated life-time cancer risks. Clinical decision rules (CDRs) to guide imaging decisions exist, although two of the existing rules, the National Emergency X-Radiography Low Risk Criteria and the Canadian C-Spine Rule (CCR), focus on adults and a newly developed paediatric rule from the Pediatric Emergency Care Applied Research Network (PECARN) is yet to be externally validated. This study aims to externally validate these three CDRs in children. Methods and analysis This is a multicentre prospective observational study of children younger than 16 years presenting with possible CSI following blunt trauma to 1 of 14 EDs across Australia, New Zealand and Singapore. Data will be collected on presenting features (history, injury mechanism, physical examination findings) and management (diagnostic imaging, admission, interventions, outcomes). The performance accuracy (sensitivity, specificity, negative and positive predictive values) of three existing CDRs in identifying children with study-defined CSIs and the specific CDR defined outcomes will be determined, along with multiple secondary outcomes including CSI epidemiology, investigations and management of possible CSI. Ethics and dissemination Ethics approval for the study was received from the Royal Children’s Hospital Melbourne Human Research Ethics Committee in Australia (HREC/69436/RCHM-2020) with additional approvals from the New Zealand Human and Disability Ethics Committee and the SingHealth Centralised Institutional Review Board. Findings will be disseminated through peer-reviewed publications and future management guidelines. Trial registration number Registration with the Australian New Zealand Clinical Trials Registry prior to the commencement of participant recruitment (ACTRN12621001050842). 50% of expected patients have been enrolled to date.


  • Open Access

    Use of the Theoretical Domains Framework to explore factors influencing paediatric fever management practices and antipyretic use in New Zealand emergency departments

    by Eunicia Tan, Libby Haskell, Sierra Beck, Alastair MacLean, Alice Rogan, Martin Than, Bridget Venning, Christopher White, Kim Yates, Christopher JD McKinlay, et al.

    Aim To explore factors influencing fever management practices and antipyretic use among New Zealand Emergency Department (ED) doctors and nurses using the Theoretical Domains Framework (TDF). Methods Cross-sectional survey of doctors and nurses across 11 New Zealand EDs. The questionnaire examined eight of 12 TDF domains, based on a generic questionnaire validated to assess TDF-based determinants of health-care professional behaviour. Relevant domains were identified by the frequency of beliefs; the presence of conflicting beliefs within a domain; and the likely strength of impact of a belief on paediatric fever management in the ED. Results About 602 participants (243 doctors, 353 nurses and 6 unknown) completed the survey (response rate 47.5%). Over half (351/591, 59.6%, 95% confidence interval (CI) 55.5-63.5%) knew the content of clinical practice guidelines regarding antipyretic use in febrile children (TDF Domain Knowledge), or had been trained to ensure antipyretics are given to febrile children only if they appear distressed (347/592, 58.6%, 95% CI 54.5-62.6%) (Skills). Over 40% (246/590, 95% CI 37.7-45.8%) aim to reduce the fever before discharge (Goals). Most (444/591, 75.1%, 95% CI 71.4-78.6%) participants felt capable of explaining appropriate antipyretic use to parents/care givers (Beliefs about Capabilities). Only a minority (155/584, 26.5%, 95% CI 23.0-30.3%) thought that they can ensure antipyretics are given to febrile children only if they appear distressed when the ED is busy (Environmental Context and Resources). Conclusions Using the TDF, we identified factors influencing fever management practices and antipyretic use in the ED. These factors can guide the design of targeted, theory-informed knowledge translation strategies.


  • Open Access

    Paediatric fever management practices and antipyretic use among doctors and nurses in New Zealand emergency departments

    by Eunicia Tan, Sierra Beck, Libby Haskell, Alastair MacLean, Alice Rogan, Martin Than, Bridget Venning, Christopher White, Kim Yates, Christopher JD McKinlay, et al.

    Objectives: To assess (i) paediatric fever management practices among New Zealand ED doctors and nurses, including adherence to best practice guidelines; and (ii) the acceptability of a randomised controlled trial (RCT) of antipyretics for relief of discomfort in young children.Methods: A cross‐sectional survey of doctors and nurses across 11 New Zealand EDs. The primary outcome of adherence to paediatric fever management best practice guidelines was assessed with clinical vignettes and defined as single antipyretic use for the relief of fever‐related discomfort.Results: Out of 602 participants (243 doctors, 353 nurses and six unknown; response rate 47.5%), only 64 (10.6%, 95% confidence interval [CI] 8.3–13.4%) demonstrated adherence to best practice guidelines. In a febrile settled child with normal fluid intake, the percentage of participants that would use antipyretics doubled with abnormal vital signs (33.7%vs72.9%, difference −39.2%, 95% CI –44.4% to −34.0%). Most participants would use antipyretics for reduced fluid intake (n = 494, 82.1%, 95% CI 78.8–85.0%) in a febrile settled child. Over half (n = 339, 57.1%, 95% CI 53.0–61.1%) would advise giving antipyretics to prevent febrile convulsions. Most (n = 467, 80.0%, 95% CI 76.5–83.1%) participants agreed that a RCT of antipyretics in febrile children <2 years of age with relief of discomfort as a primary outcome is needed.Conclusions: Just over 10% of New Zealand ED doctors and nurses demonstrated adherence to paediatric fever management best practice guidelines. A RCT of antipyretics in febrile children <2 years of age specifically addressing relief of discomfort as a primary outcome is strongly supported.


  • Open Access

    Panic or peace – prioritising infant welfare when medicating feverish infants: a grounded theory study of adherence in a paediatric clinical trial

    by Eunicia Tan, Karen Hoare, Judith Riley, Kathryn Fernando, Libby Haskell, Christopher JD McKinlay, Stuart R Dalziel, Irene Braithwaite

    Literature on factors influencing medication adherence within paediatric clinical trials is sparse. The Paracetamol and Ibuprofen in the Primary Prevention of Asthma in Tamariki (PIPPA Tamariki) trial is an open-label, randomised controlled trial aiming to determine whether paracetamol treatment, compared with ibuprofen treatment, as required for fever and pain in the first year of life, increases the risk of asthma at age six years. To inform strategies for reducing trial medication crossovers, understanding factors influencing the observed ibuprofen-to-paracetamol crossovers (non-protocol adherence) is vital. The aim of this study was to investigate the factors influencing the decision-making process when administering or prescribing ibuprofen to infants that may contribute to the crossover events in the PIPPA Tamariki trial. Constructivist grounded theory methods were employed. We conducted semi-structured interviews of caregivers of enrolled PIPPA Tamariki infants and healthcare professionals in various healthcare settings. Increasing theoretical sensitivity of the interviewers led to theoretical sampling of participants who could expand on the teams’ early constructed codes. Transcribed interviews were coded and analysed using the constant comparative method of concurrent data collection and analysis. Between September and December 2020, 20 participants (12 caregivers; 8 healthcare professionals) were interviewed. We constructed a grounded theory of prioritising infant welfare that represents a basic social process when caregivers and healthcare professionals medicate feverish infants. This process comprises three categories: historical, trusting relationships and being discerning; and is modified by one condition: being conflicted. Participants bring with them historical ideas. Trusting relationships with researchers, treating clinicians and family play a central role in enabling participants to challenge historical ideas and be discerning. Trial medication crossovers occur when participants become conflicted, and they revert to historical practices that feel familiar and safer. We identified factors and a basic social process influencing ibuprofen use in infants and trial medication crossover events, which can inform strategies for promoting adherence in the PIPPA Tamariki trial. Future studies should explore the role of trusting relationships between researchers and treating clinicians when conducting research.


  • Open Access

    Fever phobia in caregivers presenting to New Zealand emergency departments

    by Donagh MacMahon, Christine Brabyn, Stuart R Dalziel, Christopher JD McKinlay, Eunicia Tan

    Objective: To determine the prevalence of fever phobia among caregivers of children presenting to New Zealand EDs.Methods: A cross‐sectional survey was administered to caregivers of children n = 383, 87.6% [95% CI 84.2–90.4%]) knew the correct dosing interval for paracetamol, compared to less than half of caregivers (n = 179, 42.5% [95% CI 37.9–47.3%]) for ibuprofen. Caregivers reported non‐evidence‐based fever management practices such as sponging, always giving paracetamol and/or ibuprofen for fever, and waking children from sleep to give antipyretics. Over one‐third of caregivers identified ED doctors (n = 195, 40.2% [95% CI 34.7–43.2%]) and ED nurses (n = 173, 35.7% [95% CI 31.5–40.0%]) as sources of information regarding fever management. A higher level of education was associated with fever phobia (odds ratio 1.68 [95% CI 1.04–2.72], P = 0.04).Conclusions: Fever phobia is prevalent among caregivers of children presenting to New Zealand EDs. Opportunistic caregiver education in the ED in conjunction with public health strategies are needed to dispel undue fears and misconceptions about fever.